Fulcrum Therapeutics FULC Earnings Call Transcripts

NASDAQ FULC
$3.74 +0.02 (+0.54%)
At close: Nov 11, 2026 · 4:00 PM EST
3 earnings calls on file for Fulcrum Therapeutics, from Q4 2019 to Q1 2026. Each transcript opens in a new tab.
Latest earnings call

Fulcrum Therapeutics Q1 2026 Earnings Call

Apr 27, 2026 5,009 words · 22 min read
  • Alexander SapirChief Executive Officer
  • Alan MussoChief Financial Officer
  • Iain FraserChief Medical Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Fulcrum Therapeutics Earnings Call Transcripts

Calls3
LatestApr 27, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2020

Fiscal 2019

All 3 Fulcrum Therapeutics transcripts Register to get access to Fulcrum Therapeutics’s earnings call transcripts.